TOP STORIES
respiratory
COPD

PBS broadens access to COPD triple therapy and lung cancer immunotherapy

For COPD patients the PBS is to remove the clinical criteria restricting access to patients with a FEV1 <50% of predicted for triple therapy Trelegy (fluticasone furoate with umeclidinium and vilanterol) from 1 March 2020. The move is expected to allow...

For COPD patients the PBS is to remove the clinical criteria restricting access to patients with a FEV1 <50% of...

Read more
Asthma

FOT better than spirometry for identifying poor asthma control

An alternative method for measuring lung function, oscillometry, is better at identifying patients with poorly controlled asthma when compared to spirometry, according to NSW researchers Measurement of bronchodilator response (BDR) with the...

An alternative method for measuring lung function, oscillometry, is better at...
Cystic fibrosis

Novel therapy success for ‘untreatable’ P. aeruginosa in CF lung transplant patient

Doctors in Queensland have successfully treated a life-threatening P. aeruginosa infection in a post–lung transplant patient with cystic fibrosis by using used plasmapheresis to eliminate inhibitory IgG2 antibodies that were blocking the effects of antibiotics. The 33-year old man Jordan Trieger had...

Doctors in Queensland have successfully treated a life-threatening P. aeruginosa infection in a post–lung transplant patient with cystic fibrosis by using...
medical education

RACP training program gets 79% approval rating from participants

Trainees with the Royal Australasian College of Physicians (RACP) specialist program have given a mostly positive feedback in the Medical Training Survey 2019 conducted by the Medical Board of Australia and AHPRA. Survey data was obtained from 1333 doctors in...

Trainees with the Royal Australasian College of Physicians (RACP) specialist program have given a mostly positive feedback in the ...